The heads of FDA and CMS are outlining a vision for collaboration on development of real-world evidence ahead of the transition to a new presidential administration.
FDA Commissioner Robert Califf, Deputy Commissioner for Medical Products Rachel Sherman, and Acting CMS Administrator Andy Slavitt published a “viewpoint” piece entitled, “Knowing When and How to Use...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?